...
首页> 外文期刊>American Journal of Case Reports >Pars plana vitrectomy with silicone oil endotamponade in an eye with previously treated retinoblastoma
【24h】

Pars plana vitrectomy with silicone oil endotamponade in an eye with previously treated retinoblastoma

机译:在先前治疗过的视网膜母细胞瘤眼中使用硅油内填塞治疗帕氏玻璃体切除术

获取原文
           

摘要

Background: As conservative treatments for retinoblastoma become more prevalent, the number of ocular complications developing in eyes that previously would have been enucleated is growing.Case Report: The aim of the study is to present the case of a 19-year-old patient who was referred to this department at the age of 7 months with suspected bilateral retinoblastoma. One month later, enucleation of the right eye (Reese-Ellswoth group V) was performed and histopatological examination confirmed retinoblastoma. Brachytherapy and xenon arc photocoagulations were performed in the left eye. After the treatment, visual acuity (VA) of the left eye was 1.0. At the age of 17 years, intravitreal hemorrhage occurred in the left eye. As a result of pharmacological treatment, proper function of the left eye was restored. After two subsequent hemorrhages, VA was restricted to hand movements. The left eye was qualified for pars plana vitrectomy (PPV) with silicon oil tamponade. The follow-up examinations showed improvement of VA to 0.5. The patient passed her high school final exams. She has remained under ophtalmological and oncological supervision. Observation has shown no recurrence or metastatic spread of the tumor.Conclusions: PPV with silicone oil endotamponade can be regarded as a treatment option in complicated cases of retinoblastoma. However, it may be associated with risks of tumor recurrence and systemic dissemination; therefore this technique should be reserved for patients with no alternative for preserving vision.
机译:背景:随着视网膜母细胞瘤的保守治疗变得越来越普遍,以前应摘除的眼内发生的眼部并发症的数量也在增加。病例报告:本研究的目的是介绍一名19岁的患者因怀疑双侧视网膜母细胞瘤在7个月大时被转诊至该科。一个月后,进行右眼摘除术(Reese-Ellswoth V组),组织学检查证实为视网膜母细胞瘤。左眼进行近距离放射治疗和氙弧光凝。治疗后,左眼视力(VA)为1.0。在17岁时,左眼发生玻璃体内出血。通过药物治疗,恢复了左眼的正常功能。在随后的两次出血后,VA只能进行手部活动。左眼有资格使用硅油填塞剂进行平板玻璃体切除术(PPV)。随访检查显示VA增加至0.5。病人通过了高中期末考试。她一直受到眼科和肿瘤学的监督。观察结果未见肿瘤复发或转移。结论:PPV联合硅油内填塞可作为视网膜母细胞瘤复杂病例的治疗选择。但是,它可能与肿瘤复发和全身扩散的风险有关。因此,该技术应保留给无保留视力的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号